Carlos Campoy

Chief Financial Officer, ALDER BIOPHARMACEUTICALS INC.

Companies

ZymeworksBoard member Jun 30, 2023 to now¹
CytomX Therapeutics, Inc.Chief financial officer Mar 25, 2020 to Mar 20, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CytomX Therapeutics, Inc. CTMX38,224 shares³$87.9K at $2.30Mar 16, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 16, 2023Sold 1,748 shares at $1.98 of CytomX Therapeutics, Inc.³
Jul 20, 2022Sold 3,949 shares at $1.42 of CytomX Therapeutics, Inc.⁴
Jul 19, 2022Granted 15,000 shares of CytomX Therapeutics, Inc.⁴
Feb 2, 2022Granted 22,500 shares of CytomX Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZymeworks, Board member
2
SEC EDGARCytomX Therapeutics, Inc., Chief financial officer
3
SEC EDGARCytomX Therapeutics, Inc. shares after the filing of Mar 16, 2023
4
SEC EDGARForm 4 filed Jul 21, 2022
5
SEC EDGARForm 4 filed Feb 4, 2022